DAVID NIELSEN to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications DAVID NIELSEN has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.106
-
DBH gene as predictor of response in a cocaine vaccine clinical trial. Neurosci Lett. 2013 Apr 29; 541:29-33.
Score: 0.106
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.